Nurix Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $907k | 98k | 9.24 |
| 2025-06-30 | $2.6M | 232k | 11.39 |
| 2025-03-31 | $1.9M | 160k | 11.88 |
| 2024-12-31 | $2.8M | 147k | 18.84 |
| 2024-09-30 | $2.9M | 129k | 22.47 |
| 2024-06-30 | $2.7M | 129k | 20.87 |
| 2023-09-30 | $1.9M | 241k | 7.86 |
| 2023-06-30 | $2.2M | 247k | 8.88 |
| 2023-03-31 | $2.2M | 247k | 8.88 |
| 2022-12-31 | $2.7M | 246k | 10.98 |
| 2022-09-30 | $3.0M | 231k | 13.03 |
| 2022-06-30 | $3.1M | 244k | 12.67 |
| 2022-03-31 | $3.5M | 253k | 14.01 |
| 2021-12-31 | $8.1M | 279k | 28.95 |
| 2021-09-30 | $8.6M | 286k | 29.96 |
| 2021-06-30 | $7.6M | 286k | 26.53 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas